Edition:
United States

Invitae Corp (NVTA.N)

NVTA.N on New York Stock Exchange

8.65USD
22 Nov 2017
Change (% chg)

$0.20 (+2.37%)
Prev Close
$8.45
Open
$8.45
Day's High
$8.68
Day's Low
$8.34
Volume
121,350
Avg. Vol
82,123
52-wk High
$11.88
52-wk Low
$6.65

Chart for

About

Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016,... (more)

Overall

Beta: --
Market Cap(Mil.): $447.39
Shares Outstanding(Mil.): 52.95
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 200.71 15.46
EPS (TTM): -- -- --
ROI: -- -10.20 11.85
ROE: -- -36.19 15.83

BRIEF-Combimatrix Corp stockholders approve merger agreement with Invitae Corp

* Combimatrix Corporation stockholders approve merger agreement with Invitae Corporation

Nov 10 2017

BRIEF-Invitae posts Q3 loss per share $0.57

* Invitae reports double-digit sequential volume and revenue growth in third quarter 2017

Nov 06 2017

BRIEF-CombiMatrix Corp says co's unit entered into Marketing and Laboratory Services Agreement with Invitae Corp and its unit

* CombiMatrix Corp - ‍on Sept 25, co's unit CombiMatrix Molecular Diagnostics Inc entered into marketing and laboratory services agreement with Invitae Corp and its unit

Sep 27 2017

BRIEF-Invitae says selling stockholders may sell up to an aggregate of 10.7 mln shares

* Invitae Corp- files to say selling stockholders may sell up to an aggregate of 10.7 million shares of co's common stock - sec filing‍​ Source text: (http://bit.ly/2woWQh5) Further company coverage:

Aug 18 2017

BRIEF-Invitae says selling stockholders may sell up to aggregate of 5.2 mln shares

* Invitae Corp - selling stockholders may sell up to aggregate of 5.2 million shares of co's stock‍​‍​ Source text: (http://bit.ly/2wad8uF) Further company coverage:

Aug 18 2017

BRIEF-Invitae Q2 loss per share $0.66

* Q2 earnings per share view $-0.62 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Aug 07 2017

BRIEF-Invitae says expects 120,000-130,000 samples accessioned in 2017

* Increasing guidance on volume, now sees 120,000-130,000 samples accessioned in 2017 Source text for Eikon: (http://bit.ly/2f4CMtJ) Further company coverage:

Aug 01 2017

BRIEF-Invitae posts Q2 loss of $0.66/shr and also reports $73.5 mln private placement offering

* Invitae announces $73.5 million private placement offering to fuel strategic growth opportunities and reports preliminary second quarter financial results

Jul 31 2017

BRIEF-Safeguard Scientifics says its partner company, Good Start Genetics signed definitive agreement to be acquired By Invitae Corporation

* Safeguard Scientifics Inc says its partner company, Good Start Genetics, Inc., signed definitive agreement to be acquired by Invitae Corporation

Jul 31 2017

BRIEF-Combimatrix to be acquired for $33 mln in Invitae common stock

* Combimatrix enters into merger agreement with Invitae Corporation to be acquired for $33 million in Invitae common stock

Jul 31 2017

Earnings vs. Estimates